Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium vs Salmeterol vs Placebo in COPD
NCT02173691Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 1999
- Primary completion
- May 2000
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of tiotropium in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Trough forced expiratory volume in one second at 6 months and Transition Dyspnoea Index focal score at 6 months. Started Feb 1999; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02173691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02173691.